Literature DB >> 1424160

Intestinal type alkaline phosphatase hyperphosphatasemia associated with liver cirrhosis.

S Saheki1, M Ochi, T Horiuchi, Y Sakagishi, Y Fujimori-Arai, I Koyama, T Komoda, N Takeuchi.   

Abstract

Hyperphosphatasemia due to increased intestinal type serum alkaline phosphatase was noted in a 48-year-old male who had asymptomatic liver cirrhosis. The alkaline phosphatase activity in the serum was 828 U/l (our reference range in adults: 57-194 U/l), 94% of which was of the intestinal type as measured by an immunoprecipitation method. The intestinal component of alkaline phosphatase was separated into two major and some minor components using electrophoresis and isoelectrofocusing. One of the major components had similar mobility to that of a standard intestinal enzyme purified from adult intestine. The components were heat-labile and neuraminidase-resistant. Serial lectin affinity chromatography, however, indicated that sugar chain compositions of the alkaline phosphatase were different from those of the standard tissue intestinal enzyme. These results and further enzymological studies suggest that the patient's serum alkaline phosphatase basically consisted of several intestine-like isoforms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424160     DOI: 10.1016/0009-8981(92)90046-s

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Human tissue non-specific alkaline phosphatases: sugar-moiety-induced enzymic and antigenic modulations and genetic aspects.

Authors:  O Nosjean; I Koyama; M Goseki; B Roux; T Komoda
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

2.  High-molecular intestinal alkaline phosphatase by agarose gel electrophoresis.

Authors:  Kinue Ooi; Katsuya Shiraki; Yoshitaka Morishita; Tsutomu Nobori
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

3.  High-molecular intestinal alkaline phosphatase in chronic liver diseases.

Authors:  Kinue Ooi; Katsuya Shiraki; Yoshitaka Morishita; Tsutomu Nobori
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.